Addressing Health Inequities in Cancer Screening: Challenges and Opportunities
Explore critical issues surrounding health disparities in cancer screening, as discussed by experts, and the urgent need to bridge gaps in access, trust, and follow-up care for underserved populations.
Cancer Screening and Management: Overview of the Current Landscape
A panel of esteemed cancer experts explore the challenges and opportunities in cancer screening and identification, shedding light on the evolving landscape and its impact on clinical practice.
Dr. O’Donnell on the Ideal Patients for CAR T-Cell Therapies
Betsy O'Donnell, MD, discusses the ideal patients for CAR T-cell therapies in multiple myeloma.
Dr. O’Donnell on the Promise of Novel Targets in Multiple Myeloma
Betsy O'Donnell, MD, discusses the promise of novel targets in multiple myeloma.
Dr. O'Donnell Discusses Ongoing Research Efforts in Multiple Myeloma
Betsy O'Donnell, MD, discusses ongoing research efforts in multiple myeloma.
Dr. O'Donnell on Transplant Considerations in Multiple Myeloma
Betsy O'Donnell, MD, discusses transplant considerations in patients with multiple myeloma.
Dr. O'Donnell on Up-front Triplets in Multiple Myeloma
Betsy O'Donnell, MD, discusses the utility of up-front triplet regimens in multiple myeloma.
Dr. O'Donnell on Unanswered Questions in Multiple Myeloma
Betsy O’Donnell, MD, discusses unanswered questions in multiple myeloma.
Axatilimab Elicits Responses With Manageable Safety in Recurrent/Refractory cGVHD
Dr Bal on Updated Findings With BMS-986393 in Relapsed/Refractory Multiple Myeloma
Dr Ghia on a Biomarker Analysis of the SEQUOIA Trial in CLL/SLL
Oral DEC-C Treatment Is Feasible and Comparable With IV/SC HMA Outcomes in MDS
2 Clarke Drive Cranbury, NJ 08512